Sonoma Pharmaceuticals (SNOA) Profit After Tax Growth (3y) (2013 - 2026)
Sonoma Pharmaceuticals (SNOA) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,435.17 | 2.58 Mn | 38.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.49% |
| Mar 31, 2026 | -4.80% |
| Dec 31, 2025 | 24.97% |
| Sep 30, 2025 | 19.32% |
| Jun 30, 2025 | -11.84% |
| Mar 31, 2025 | 33.75% |
| Dec 31, 2024 | 0.57% |
| Sep 30, 2024 | -82.72% |
| Jun 30, 2024 | -1.35% |
| Mar 31, 2024 | 15.63% |
| Dec 31, 2023 | 3.13% |
| Sep 30, 2023 | -127.84% |
| Jun 30, 2023 | -99.23% |
| Mar 31, 2023 | 28.17% |
| Dec 31, 2022 | -17.02% |
| Sep 30, 2022 | 7.57% |
| Jun 30, 2022 | -47.98% |
| Mar 31, 2022 | 5.90% |
| Dec 31, 2021 | 28.56% |
| Sep 30, 2021 | 67.15% |